ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $43,000 | +87.0% | 25,258 | +33.6% | 0.00% | – |
| Q4 2020 | $23,000 | -39.5% | 18,906 | +13.5% | 0.00% | – |
| Q4 2018 | $38,000 | -24.0% | 16,663 | +28.3% | 0.00% | – |
| Q3 2018 | $50,000 | +16.3% | 12,984 | +0.9% | 0.00% | – |
| Q2 2018 | $43,000 | -63.9% | 12,865 | -66.0% | 0.00% | – |
| Q1 2017 | $119,000 | +36.8% | 37,802 | +13.3% | 0.00% | – |
| Q4 2016 | $87,000 | -28.7% | 33,359 | +6.0% | 0.00% | – |
| Q3 2016 | $122,000 | +43.5% | 31,468 | -0.8% | 0.00% | – |
| Q2 2016 | $85,000 | -95.5% | 31,707 | -82.8% | 0.00% | -100.0% |
| Q2 2014 | $1,887,000 | -52.7% | 184,137 | -44.5% | 0.00% | -50.0% |
| Q1 2014 | $3,986,000 | +55.2% | 331,892 | +46.1% | 0.00% | +100.0% |
| Q4 2013 | $2,569,000 | – | 227,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 62,000 | $216,000 | 0.20% |
| Monashee Investment Management LLC | 187,190 | $651,000 | 0.15% |
| Cedar Wealth Management, LLC | 46,395 | $161,000 | 0.10% |
| BCWM, LLC | 35,100 | $122,000 | 0.06% |
| Tibra Equities Europe Ltd | 149,595 | $521,000 | 0.05% |
| Ahrens Investment Partners LLC | 30,900 | $108,000 | 0.05% |
| ExodusPoint Capital Management, LP | 151,904 | $529,000 | 0.04% |
| Laurion Capital Management LP | 833,400 | $2,900,000 | 0.04% |
| Alpine Global Management, LLC | 33,928 | $118,000 | 0.03% |
| Cornerstone Capital, Inc. | 57,550 | $200,000 | 0.03% |